Stepwise analysis of MIR9 loci identifies MIR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Barbano, Raffaela ^a   Pasculli, Barbara ^a   Rendina, Michelina ^a   Fontana, Andrea ^a   Fusilli, Caterina ^a   Copetti, Massimiliano ^a   Castellana, Stefano ^a   Valori, Vanna Maria ^a   Morritti, Maria ^a   Graziano, Paolo ^a   Luigi, Ciuffreda ^a   Coco, Michelina ^a   Picardo, Francesco ^b   Mazza, Tommaso ^a   Evron, Ella ^c   Murgo, Roberto ^a   Maiello, Evaristo ^a   Esteller, Manel ^d,e,f   Fazio, Vito Michele ^a,b   Parrella, Paola ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c TEL AVIV UNIVERSITY   (Israel)

^d HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^e INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^f UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; MICRORNA; MIRN92 MICRORNA, HUMAN; TUMOR MARKER;

AGED; BREAST TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOCUS; GENETICS; HUMAN; MIDDLE AGED; PROCEDURES; PROMOTER REGION; PROSPECTIVE STUDY; SIGNAL TRANSDUCTION;

AGED; BIOMARKERS, TUMOR; BREAST NEOPLASMS; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC LOCI; HUMANS; MICRORNAS; MIDDLE AGED; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; SIGNAL TRANSDUCTION;

EID: 85016234972     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep45283     Document Type: Article

References (55)

1. Wienholds, E. et al. MicroRNA expression in zebrafish embryonic development. Science 309, 310-311 (2005).
2. Kapsimali, M. et al. MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system. Genome Biol. 8, R173, 10.1186/gb-2007-8-8-r173 (2007).
3. Otaegi, G., Pollock, A., Hong, J. & Sun, T. MicroRNA miR-9 modifies motor neuron columns by a tuning regulation of FoxP1 levels in developing spinal cords. J Neurosci. 31, 809-818 (2011).
4. Bonev, B., Pisco, A. & Papalopulu N. MicroRNA-9 reveals regional diversity of neural progenitors along the anterior-posterior axis. Dev. Cell. 20, 19-32 (2011).
5. Shibata, M., Nakao, H., Kiyonari, H., Abe, T. & Aizawa, S. MicroRNA-9 regulates neurogenesis in mouse telencephalon by targeting multiple transcription factors. J. Neurosci. 31, 3407-3422 (2011).
6. Roese-Koerner, B. et al. Reciprocal Regulation between Bifunctional miR-9/9(∗ ) and its Transcriptional Modulator Notch in Human Neural Stem Cell Self-Renewal and Differentiation. Stem Cell Reports 7, 207-219 (2016).
7. Lujambio, A. et al. A microRNA DNA methylation signature for human cancer metastasis. Proc. Natl. Acad. Sci. USA 105, 13556-13561 (2008).
8. Lehmann, U. et al. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J. Pathol. 214, 17-24 (2008).
9. Muraoka, T. et al. Impact of aberrant methylation of microRNA-9 family members on non-small cell lung cancers. Mol. Clin. Oncol. 1, 185-189 (2013).
10. Bandres, E. et al. Epigenetic regulation of microRNA expression in colorectal cancer. Int. J. Cancer 125, 2737-2743 (2009).
11. Luo, H. et al. Down-regulated miR-9 and miR-433 in human gastric carcinoma. J. Exp. Clin. Cancer Res. 28, 82, 10.1186/1756-9966-28-82 (2009).
12. Hildebrandt, M. A. et al. hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma. Oncogene 29, 5724-5728 (2010).
13. Hsu, P. Y. et al. Xenoestrogen induced epigenetic repression of microRNA-9-3 in breast epithelial cells. Cancer Res. 69, 5936-5945 (2009).
14. Ebrahimi-Askari, R., Behmanesh, M. & Soleimani, M. Analyses of methylation status of CpG islands in promoters of miR-9 genes family in human gastric adenocarcinoma. MBRC 4, 73-82 (2015).
15. Laios, A. et al. Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol. Cancer 7, 35 10.1186/1476-4598-7-35 (2008).
16. Guo, L. M. et al. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NFK-B1. FEBS J 276, 5537-5546 (2009).
17. Guled, M. et al. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma. A miRNA microarray analysis. Genes Chromosomes Cancer 48, 615-623 (2009).
18. Nass, D. et al. MiR-92b and miR-9/9∗ are specifically expressed in brain primary tumours and can be used to differentiate primary from metastatic brain tumours. Brain Pathol. 19, 375-383 (2009).
19. Xu, S. H., Yang, Y. L., Han, S. M. & Wu, Z. H. MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma. World J. Surg. Oncol. 12, 195, 10.1186/1477-7819-12-195 (2014).
20. Cai, L. & Cai, X. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma. Diagnostic Pathology. 9, 1000, 10.1186/s13000-014-0228-2 (2014).
21. Liu, X., Luo, Z., Peng, H., Jiang, H. & Xu, L. Prognostic role of miR-9 expression in various human malignant neoplasms: a metaanalysis. Onco Targets Ther. 9, 3039-3047 (2016).
22. Selcuklu, S. D. et al. MicroRNA-9 Inhibition of Cell Proliferation and Identification of Novel miR-9 Targets by Transcriptome Profiling in Breast Cancer Cells. J. Biol. Chem. 287, 29516-29528 (2012).
23. Zhou, X. et al. MicroRNA-9 as potential biomarker for breast cancer local recurrence and tumor estrogen receptor status. PLoS One 7, e39011, 10.1371/journal.pone.0039011 (2012).
24. D'Ippolito, E. et al. MiR-9 and miR-200 regulate PDGFRβ -mediated endothelial differentiation of tumour cells in triple negative breast cancer. Cancer Res. 76, 5562-5572 (2016).
25. Ma, L. et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12, 247-256 (2010).
26. Baroni, S. et al. Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts. Cell. Death Dis. 7, e2312, 10.1038/cddis.2016.224 (2016).
27. Slattery, M. L. et al. An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality. Int J Cancer. 137, 428-438 (2015).
28. Higashi, T. et al. miR-9-3p plays a tumour suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells. Br J Cancer. 113, 252-258 (2015).
29. Zawistowski J. S. et al. MicroRNA 9-3p targets β 1 integrin to sensitize claudin-low breast cancer cells to MEK inhibition. Mol Cell Biol. 33, 2260-2274 (2013).
30. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747-752 (2000).
31. The Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumors. Nature. 490, 61-70, doi: 10.1038/ nature11412 (2012).
32. Pillai, M. M. et al. HITS-CLIP reveals key regulators of Nuclear Receptor signaling in breast cancer. Breast Cancer Res. Treat. 146, 85-97 (2014).
33. Karginov, F. V. & Hannon, G. I. Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. Genes Dev. 27, 1624-1632 (2013).
34. Munagala, R., Aqil, F., Vadhanam, M. V. & Gupta, R. C. MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention. Cancer Lett. 2013 339, 175-184 (2013).
35. Nelson, P. T. et al. RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. RNA 12, 187-191 (2006).
36. Baylin, S. B. & Jones, P. A. A decade of exploring the cancer epigenome - biological and translational implications. Nat. Rev. Cancer. 11, 726-734 (2011).
37. Esteller, M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum. Mol. Genet. 16, R50-59 (2007).
38. Cimmino, L., Abdel-Wahab, O., Levine, R. L. & Aifantis, I. TET family proteins and their role in stem cell differentiation and transformation. Cell Stem Cell 9, 193-204 (2011).
39. Wu, H. & Zhang, Y. Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell 156, 45-68 (2014).
40. Hurtado, A., Holmes, K. A., Ross-Innes, C. S., Schmidt, D. & Carroll, J. S. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat Genet. 43, 27-33 (2011).
41. Zhang, Y. et al. Nucleation of DNA repair factors by FOXA1 links DNA demethylation to transcriptional pioneering. Nat Genet. 48, 1003-1013 (2016).
42. Kong, S. L., Li, G., Loh, S. L., Sung, W. K. & Liu E. T. Cellular reprogramming by the conjoint action of ERα , FOXA1, and GATA3 to a ligand-inducible growth state. Mol Syst Biol. 30, 526, doi: 10.1038/msb.2011.59. (2011).
43. Osborne, C. K., Shou, J., Massarweh, S. & Schiff, R. Crosstalk between Estrogen Receptor and Growth Factor Receptor Pathways as a Cause for Endocrine Therapy Resistance in Breast Cancer. Clin. Canc. Res. 11, 865s-870s (2005).
44. Montagna, E. et al. Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy. Ann. Oncol. 26, 307-313 (2005).
45. McShane, L. M. et al. Statistics subcommittee of the NCI-EORTC working group on cancer diagnostics. Reporting recommendations for tumor marker prognostic studies. J. Clin. Oncol. 23, 9067-72 (2005).
46. Hammond, M. E. et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J. Clin. Oncol. 28, 2784-2795 (2010).
47. Wolff, A. C. et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol 31, 3997-4013 (2013).
48. Parrella P. et al. Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients. Mol. Cancer 13, 142, doi: 10.1186/1476-4598-13-142 (2014).
49. Parrella, P. et al. Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. Clin. Cancer Res. 10, 5349-54 (2004).
50. Bailey, T. L. et al. MEME SUITE: tools for motif discovery and searching, Nucleic Acids Res. 37 (Web Server issue), . W202-208 (2009).
51. Medina-Rivera, A. et al. RSAT 2015: Regulatory Sequence Analysis Tools. Nucleic Acids Res. 43, W50-W56 (2015).
52. Sandelin, A., Alkema, W., Engström, P., Wasserman, W. W. & Lenhard, B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 32, D91-D94 (2004).
53. Yates, A. et al. Ensembl 2016. Nucleic Acids Res. 44, D710-D716 (2016).
54. Karolchik D., Hinrichs A. S., Furey T. S., Roskin K. M., Sugnet C. W., Haussler D. & Kent W. J. The UCSC Table Browser data retrieval tool. Nucleic Acids Res. 32, D493-496 (2004).
55. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 489, 57-74 (2012).